Published in Proc Natl Acad Sci U S A on July 02, 2003
AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol (2009) 3.40
Human -defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2. Proc Natl Acad Sci U S A (2007) 2.10
Multidimensional signatures in antimicrobial peptides. Proc Natl Acad Sci U S A (2004) 2.00
Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection. J Virol (2005) 1.75
Crystal structures of human alpha-defensins HNP4, HD5, and HD6. Protein Sci (2006) 1.68
Antimicrobial characterization of human beta-defensin 3 derivatives. Antimicrob Agents Chemother (2003) 1.63
The roles of antimicrobial peptides in innate host defense. Curr Pharm Des (2009) 1.58
Human defensins facilitate local unfolding of thermodynamically unstable regions of bacterial protein toxins. Immunity (2014) 1.55
Antimicrobial peptides in the oral environment: expression and function in health and disease. Curr Issues Mol Biol (2005) 1.55
Induction of group A Streptococcus virulence by a human antimicrobial peptide. Proc Natl Acad Sci U S A (2008) 1.45
Human β-D-3 Exacerbates MDA5 but Suppresses TLR3 Responses to the Viral Molecular Pattern Mimic Polyinosinic:Polycytidylic Acid. PLoS Genet (2015) 1.38
Insight into the mechanisms of adenovirus capsid disassembly from studies of defensin neutralization. PLoS Pathog (2010) 1.34
The role of antimicrobial peptides at the ocular surface. Ophthalmic Res (2008) 1.32
Polymorphic segmental duplications at 8p23.1 challenge the determination of individual defensin gene repertoires and the assembly of a contiguous human reference sequence. BMC Genomics (2004) 1.32
Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals? Int J Antimicrob Agents (2011) 1.28
Human β-defensin 3 affects the activity of pro-inflammatory pathways associated with MyD88 and TRIF. Eur J Immunol (2011) 1.27
Human beta-defensin 3 has immunosuppressive activity in vitro and in vivo. Eur J Immunol (2010) 1.26
Through the looking glass, mechanistic insights from enantiomeric human defensins. J Biol Chem (2009) 1.25
Antimicrobial peptides in human skin disease. Eur J Dermatol (2007) 1.17
The conserved salt bridge in human alpha-defensin 5 is required for its precursor processing and proteolytic stability. J Biol Chem (2008) 1.16
Paneth cell α-defensins in enteric innate immunity. Cell Mol Life Sci (2011) 1.16
Novel synthetic, salt-resistant analogs of human beta-defensins 1 and 3 endowed with enhanced antimicrobial activity. Antimicrob Agents Chemother (2010) 1.14
Host defense peptides as effector molecules of the innate immune response: a sledgehammer for drug resistance? Int J Mol Sci (2009) 1.08
Osteoblasts participate in the innate immunity of the bone by producing human beta defensin-3. Histochem Cell Biol (2008) 1.07
Structure-dependent functional properties of human defensin 5. FEBS Lett (2007) 1.07
Antifungal proteins: More than antimicrobials? Fungal Biol Rev (2013) 1.04
Antibacterial activity of human neutrophil defensin HNP-1 analogs without cysteines. Antimicrob Agents Chemother (2005) 1.02
Human alpha-defensins inhibit hemolysis mediated by cholesterol-dependent cytolysins. Infect Immun (2009) 1.01
Human beta-defensin 2 and beta-defensin 3 chimeric peptides reveal the structural basis of the pathogen specificity of their parent molecules. Antimicrob Agents Chemother (2010) 1.01
Beta-defensins: what are they really doing in the oral cavity? Oral Dis (2011) 0.99
Human defensin 5 disulfide array mutants: disulfide bond deletion attenuates antibacterial activity against Staphylococcus aureus. Biochemistry (2011) 0.99
Antifungal activities of human beta-defensins HBD-1 to HBD-3 and their C-terminal analogs Phd1 to Phd3. Antimicrob Agents Chemother (2008) 0.99
Defensins: antifungal lessons from eukaryotes. Front Microbiol (2014) 0.99
The Toll-like receptor 1/2 agonists Pam(3) CSK(4) and human β-defensin-3 differentially induce interleukin-10 and nuclear factor-κB signalling patterns in human monocytes. Immunology (2011) 0.97
Specific binding and chemotactic activity of mBD4 and its functional orthologue hBD2 to CCR6-expressing cells. J Biol Chem (2010) 0.96
In vitro activation of the rhesus macaque myeloid alpha-defensin precursor proRMAD-4 by neutrophil serine proteinases. J Biol Chem (2008) 0.95
The antimicrobial activity of CCL28 is dependent on C-terminal positively-charged amino acids. Eur J Immunol (2010) 0.94
The synthetic form of a novel chicken beta-defensin identified in silico is predominantly active against intestinal pathogens. Immunogenetics (2005) 0.94
Defensin-related peptide 1 (Defr1) is allelic to Defb8 and chemoattracts immature DC and CD4+ T cells independently of CCR6. Eur J Immunol (2009) 0.93
Functional structure of the somatomedin B domain of vitronectin. Protein Sci (2007) 0.92
Epithelial cell-derived antimicrobial peptides are multifunctional agents that bridge innate and adaptive immunity. Periodontol 2000 (2010) 0.92
Impact of pro segments on the folding and function of human neutrophil alpha-defensins. J Mol Biol (2007) 0.92
Expressed sequence tag profiling identifies developmental and anatomic partitioning of gene expression in the mouse prostate. Genome Biol (2003) 0.90
Covalent dimer species of beta-defensin Defr1 display potent antimicrobial activity against multidrug-resistant bacterial pathogens. Antimicrob Agents Chemother (2007) 0.89
Human macrophage inflammatory protein 3alpha: protein and peptide nuclear magnetic resonance solution structures, dimerization, dynamics, and anti-infective properties. Antimicrob Agents Chemother (2007) 0.87
Defensins couple dysbiosis to primary immunodeficiency in Crohn's disease. World J Gastroenterol (2011) 0.87
Post-translational Modifications of Natural Antimicrobial Peptides and Strategies for Peptide Engineering. Curr Biotechnol (2012) 0.86
Antimicrobial activities of chemokines: not just a side-effect? Front Immunol (2012) 0.86
Nonviral human beta defensin-3 expression in a bioengineered human skin tissue: a therapeutic alternative for infected wounds. Wound Repair Regen (2012) 0.86
Membrane damage and repair in primary monocytes exposed to human β-defensin-3. J Leukoc Biol (2012) 0.86
Chimeric beta-defensin analogs, including the novel 3NI analog, display salt-resistant antimicrobial activity and lack toxicity in human epithelial cell lines. Antimicrob Agents Chemother (2013) 0.85
Topology of the disulfide bonds in the antiviral lectin scytovirin. Protein Sci (2010) 0.83
Multivalent Antimicrobial Peptides as Therapeutics: Design Principles and Structural Diversities. Int J Pept Res Ther (2010) 0.83
Do β-defensins and other antimicrobial peptides play a role in neuroimmune function and neurodegeneration? ScientificWorldJournal (2012) 0.83
The cyclic cystine ladder in θ-defensins is important for structure and stability, but not antibacterial activity. J Biol Chem (2013) 0.82
Modification of chicken avian beta-defensin-8 at positively selected amino acid sites enhances specific antimicrobial activity. Immunogenetics (2007) 0.81
Human β defensin-3 induces chemokines from monocytes and macrophages: diminished activity in cells from HIV-infected persons. Immunology (2013) 0.81
Membrane disruptive antimicrobial activities of human β-defensin-3 analogs. Eur J Med Chem (2014) 0.81
Functional consequences of retro-inverso isomerization of a miniature protein inhibitor of the p53-MDM2 interaction. Bioorg Med Chem (2013) 0.81
Diminished responsiveness to human β-defensin-3 and decreased TLR1 expression on monocytes and mDCs from HIV-1-infected patients. J Leukoc Biol (2012) 0.80
Modulation of neutrophil apoptosis by antimicrobial peptides. ISRN Microbiol (2012) 0.80
Human beta-defensin 3 induces maturation of human langerhans cell-like dendritic cells: an antimicrobial peptide that functions as an endogenous adjuvant. J Invest Dermatol (2012) 0.80
Cationic host defense peptides; novel antimicrobial therapeutics against Category A pathogens and emerging infections. Pathog Glob Health (2016) 0.80
Modulation of host defense peptide-mediated human mast cell activation by LPS. Innate Immun (2015) 0.78
Peptide fragments of a beta-defensin derivative with potent bactericidal activity. Antimicrob Agents Chemother (2010) 0.78
Twin disulfides for orthogonal disulfide pairing and the directed folding of multicyclic peptides. Nat Chem (2012) 0.78
Effect of selectively introducing arginine and D-amino acids on the antimicrobial activity and salt sensitivity in analogs of human beta-defensins. PLoS One (2013) 0.78
The role of human beta-defensin-2 in bone. J Anat (2008) 0.78
Determining multiallelic complex copy number and sequence variation from high coverage exome sequencing data. BMC Genomics (2015) 0.77
Human β-defensin-3 structure motifs that are important in CXCR4 antagonism. FEBS J (2013) 0.77
Identification of a cell-penetrating peptide domain from human beta-defensin 3 and characterization of its anti-inflammatory activity. Int J Nanomedicine (2015) 0.77
Antimicrobial host defensins - specific antibiotic activities and innate defense modulation. Front Immunol (2012) 0.77
Combining flagellin and human β-defensin-3 to combat bacterial infections. Front Microbiol (2014) 0.77
Characterization of the antimicrobial peptide family defensins in the Tasmanian devil (Sarcophilus harrisii), koala (Phascolarctos cinereus), and tammar wallaby (Macropus eugenii). Immunogenetics (2016) 0.77
Native thrombocidin-1 and unfolded thrombocidin-1 exert antimicrobial activity via distinct structural elements. J Biol Chem (2011) 0.77
Structure-function analysis of Avian β-defensin-6 and β-defensin-12: role of charge and disulfide bridges. BMC Microbiol (2016) 0.77
Rattusin, an intestinal α-defensin-related peptide in rats with a unique cysteine spacing pattern and salt-insensitive antibacterial activities. Antimicrob Agents Chemother (2013) 0.77
The Disulfide Bond of the Peptide Thanatin Is Dispensible for Its Antimicrobial Activity In Vivo and In Vitro. Antimicrob Agents Chemother (2016) 0.76
The drosomycin multigene family: three-disulfide variants from Drosophila takahashii possess antibacterial activity. Sci Rep (2016) 0.75
Antimicrobial characterization of site-directed mutagenesis of porcine beta defensin 2. PLoS One (2015) 0.75
Thermodynamic instability of viral proteins is a pathogen-associated molecular pattern targeted by human defensins. Sci Rep (2016) 0.75
Structural perspectives on antimicrobial chemokines. Front Immunol (2012) 0.75
A novel role for β2-microglobulin: a precursor of antibacterial chemokine in respiratory epithelial cells. Sci Rep (2016) 0.75
Disulfide cross-linking influences symbiotic activities of nodule peptide NCR247. Proc Natl Acad Sci U S A (2016) 0.75
Human β-defensin 4 with non-native disulfide bridges exhibit antimicrobial activity. PLoS One (2015) 0.75
Molecular diversity of the antimicrobial domain of beta-defensin 3 and homologous peptides. Comp Funct Genomics (2009) 0.75
Novel synthetic analogues of avian β-defensin-12: the role of charge, hydrophobicity, and disulfide bridges in biological functions. BMC Microbiol (2017) 0.75
Antimicrobial activity does not predict cytokine response to adrenomedullin or its shortened derivatives. Mediators Inflamm (2007) 0.75
Artificial disulfide-rich peptide scaffolds with precisely defined disulfide patterns and a minimized number of isomers. Chem Sci (2017) 0.75
Kinetic and thermodynamic studies reveal chemokine homologues CC11 and CC24 with an almost identical tertiary structure have different folding pathways. BMC Biophys (2017) 0.75
Human beta-defensin-3 producing cells in septic implant loosening. J Mater Sci Mater Med (2015) 0.75
Antimicrobial peptides of multicellular organisms. Nature (2002) 23.50
Principles that govern the folding of protein chains. Science (1973) 23.40
Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest (1985) 8.63
Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science (1999) 7.86
A peptide antibiotic from human skin. Nature (1997) 7.64
Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell (1996) 6.84
Peptide antibiotics. Lancet (1997) 6.76
Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature (2001) 6.71
A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration. J Immunol Methods (1980) 6.44
Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. J Biol Chem (2000) 6.19
Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell (1997) 5.99
Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim Biophys Acta (1999) 5.85
In situ neutralization in Boc-chemistry solid phase peptide synthesis. Rapid, high yield assembly of difficult sequences. Int J Pept Protein Res (1993) 5.82
Cationic peptides: a new source of antibiotics. Trends Biotechnol (1998) 5.10
Diversity of antimicrobial peptides and their mechanisms of action. Biochim Biophys Acta (1999) 4.71
Paneth cells of the human small intestine express an antimicrobial peptide gene. J Biol Chem (1992) 4.04
Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. Biochemistry (1999) 3.88
hBD-1: a novel beta-defensin from human plasma. FEBS Lett (1995) 3.79
Primary structures of three human neutrophil defensins. J Clin Invest (1985) 3.70
Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim Biophys Acta (1999) 3.49
Defensins of vertebrate animals. Curr Opin Immunol (2002) 3.41
Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett (1996) 3.39
Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria. Antimicrob Agents Chemother (2000) 3.06
Structure, function, and inhibition of chemokines. Annu Rev Pharmacol Toxicol (2002) 2.88
Defensin-6 mRNA in human Paneth cells: implications for antimicrobial peptides in host defense of the human bowel. FEBS Lett (1993) 2.82
Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J Biol Chem (1996) 2.78
Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization. Science (1991) 2.71
Discovery of five conserved beta -defensin gene clusters using a computational search strategy. Proc Natl Acad Sci U S A (2002) 2.56
Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res (2001) 2.45
Structure, function, and membrane integration of defensins. Curr Opin Struct Biol (1995) 2.40
Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells. J Leukoc Biol (2000) 2.32
The solution structures of the human beta-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus. J Biol Chem (2001) 2.20
Interaction of cationic antimicrobial peptides with model membranes. J Biol Chem (2001) 2.16
Discovery of new human beta-defensins using a genomics-based approach. Gene (2001) 2.08
Antimicrobial peptides of vertebrates. Curr Opin Immunol (1998) 1.94
[beta]-defensins in lung host defense. Annu Rev Physiol (2002) 1.80
The structure of human beta-defensin-2 shows evidence of higher order oligomerization. J Biol Chem (2000) 1.79
Interaction of antimicrobial peptides with biological and model membranes: structural and charge requirements for activity. Biochim Biophys Acta (1999) 1.65
Purification and characterization of human neutrophil peptide 4, a novel member of the defensin family. J Biol Chem (1989) 1.56
Defensins promote fusion and lysis of negatively charged membranes. Protein Sci (1993) 1.43
Binding of amino acid side-chains to S1 cavities of serine proteinases. J Mol Biol (1997) 1.36
Structure determination of human and murine beta-defensins reveals structural conservation in the absence of significant sequence similarity. Protein Sci (2001) 1.29
Three-dimensional structure of RTD-1, a cyclic antimicrobial defensin from Rhesus macaque leukocytes. Biochemistry (2001) 1.28
The structure of human beta-defensin-1: new insights into structural properties of beta-defensins. J Biol Chem (2001) 1.21
Lipid-induced conformation and lipid-binding properties of cytolytic and antimicrobial peptides: determination and biological specificity. Biochim Biophys Acta (1999) 1.16
Mutational analysis of a plant defensin from radish (Raphanus sativus L.) reveals two adjacent sites important for antifungal activity. J Biol Chem (1997) 1.16
Engineered salt-insensitive alpha-defensins with end-to-end circularized structures. J Biol Chem (2000) 1.07
Interactions of monomeric rabbit neutrophil defensins with bilayers: comparison with dimeric human defensin HNP-2. Biochemistry (1996) 1.03
Design of salt-insensitive glycine-rich antimicrobial peptides with cyclic tricystine structures. Biochemistry (2000) 0.99
Membranolytic selectivity of cystine-stabilized cyclic protegrins. Eur J Biochem (2000) 0.94
Binding of amino acid side chains to preformed cavities: interaction of serine proteinases with turkey ovomucoid third domains with coded and noncoded P1 residues. Protein Sci (1993) 0.94
Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-beta strand cystine knot framework. Biochem Biophys Res Commun (2000) 0.81
DNAWorks: an automated method for designing oligonucleotides for PCR-based gene synthesis. Nucleic Acids Res (2002) 5.75
Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science (2002) 4.45
Alarmins: chemotactic activators of immune responses. Curr Opin Immunol (2005) 3.57
Mammalian defensins in immunity: more than just microbicidal. Trends Immunol (2002) 3.52
Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells. J Immunol (2007) 2.92
Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu Rev Immunol (2004) 2.72
Many chemokines including CCL20/MIP-3alpha display antimicrobial activity. J Leukoc Biol (2003) 2.62
Human α-defensin 6 promotes mucosal innate immunity through self-assembled peptide nanonets. Science (2012) 2.44
High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J Leukoc Biol (2006) 2.44
Alarmins: awaiting a clinical response. J Clin Invest (2012) 2.19
Bacterial c-di-GMP is an immunostimulatory molecule. J Immunol (2007) 2.13
Antibacterial activity and specificity of the six human {alpha}-defensins. Antimicrob Agents Chemother (2005) 2.11
α-Defensins in human innate immunity. Immunol Rev (2012) 2.10
Cellular pharmacology studies of shikonin derivatives. Phytother Res (2002) 2.09
Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses. J Exp Med (2008) 2.04
Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX. Proc Natl Acad Sci U S A (2009) 1.94
Granulysin activates antigen-presenting cells through TLR4 and acts as an immune alarmin. Blood (2010) 1.85
A proinflammatory chemokine, CCL3, sensitizes the heat- and capsaicin-gated ion channel TRPV1. Proc Natl Acad Sci U S A (2005) 1.82
Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells. J Exp Med (2002) 1.78
Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection. J Virol (2005) 1.75
Role of chemokines in angiogenesis: CXCL12/SDF-1 and CXCR4 interaction, a key regulator of endothelial cell responses. Microcirculation (2003) 1.71
Cutting edge: expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+FoxP3+ T regulatory cells: applicability to tumor-infiltrating T regulatory cells. J Immunol (2008) 1.71
Crystal structures of human alpha-defensins HNP4, HD5, and HD6. Protein Sci (2006) 1.68
Human alpha- and beta-defensins block multiple steps in herpes simplex virus infection. J Immunol (2006) 1.64
Antimicrobial characterization of human beta-defensin 3 derivatives. Antimicrob Agents Chemother (2003) 1.63
Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant. J Immunol (2005) 1.62
Alarmins link neutrophils and dendritic cells. Trends Immunol (2009) 1.61
Human beta-defensin 2 and 3 and their mouse orthologs induce chemotaxis through interaction with CCR2. J Immunol (2010) 1.59
Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain. Proc Natl Acad Sci U S A (2002) 1.55
The structure of human macrophage inflammatory protein-3alpha /CCL20. Linking antimicrobial and CC chemokine receptor-6-binding activities with human beta-defensins. J Biol Chem (2002) 1.53
Alarmins initiate host defense. Adv Exp Med Biol (2007) 1.52
Protein kinase C zeta is required for epidermal growth factor-induced chemotaxis of human breast cancer cells. Cancer Res (2005) 1.51
Human alpha-defensins block papillomavirus infection. Proc Natl Acad Sci U S A (2006) 1.48
Induction of group A Streptococcus virulence by a human antimicrobial peptide. Proc Natl Acad Sci U S A (2008) 1.45
Pertussis toxin by inducing IL-6 promotes the generation of IL-17-producing CD4 cells. J Immunol (2007) 1.45
Interactions between human glutamate carboxypeptidase II and urea-based inhibitors: structural characterization. J Med Chem (2008) 1.39
Co-expression of TNFR2 and CD25 identifies more of the functional CD4+FOXP3+ regulatory T cells in human peripheral blood. Eur J Immunol (2010) 1.37
Differential response of murine CD4+CD25+ and CD4+CD25- T cells to dexamethasone-induced cell death. Eur J Immunol (2004) 1.36
Glucocorticoid amplifies IL-2-dependent expansion of functional FoxP3(+)CD4(+)CD25(+) T regulatory cells in vivo and enhances their capacity to suppress EAE. Eur J Immunol (2006) 1.34
Insight into the mechanisms of adenovirus capsid disassembly from studies of defensin neutralization. PLoS Pathog (2010) 1.34
Human ribonuclease A superfamily members, eosinophil-derived neurotoxin and pancreatic ribonuclease, induce dendritic cell maturation and activation. J Immunol (2004) 1.33
Identification and Biological Characterization of Mouse beta-defensin 14, the orthologue of human beta-defensin 3. J Biol Chem (2007) 1.32
BALB/c mice have more CD4+CD25+ T regulatory cells and show greater susceptibility to suppression of their CD4+CD25- responder T cells than C57BL/6 mice. J Leukoc Biol (2005) 1.31
Selective inactivation of CCR5 and decreased infectivity of R5 HIV-1 strains mediated by opioid-induced heterologous desensitization. J Leukoc Biol (2003) 1.30
Chemotactic activity of S100A7 (Psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15. J Immunol (2008) 1.30
D-peptide inhibitors of the p53-MDM2 interaction for targeted molecular therapy of malignant neoplasms. Proc Natl Acad Sci U S A (2010) 1.29
A remote arene-binding site on prostate specific membrane antigen revealed by antibody-recruiting small molecules. J Am Chem Soc (2010) 1.29
Cervicovaginal secretions contribute to innate resistance to herpes simplex virus infection. J Infect Dis (2005) 1.29
Angiogenic effects of prostaglandin E2 are mediated by up-regulation of CXCR4 on human microvascular endothelial cells. Blood (2003) 1.29
Shikonin, a component of chinese herbal medicine, inhibits chemokine receptor function and suppresses human immunodeficiency virus type 1. Antimicrob Agents Chemother (2003) 1.29
Toward understanding the cationicity of defensins. Arg and Lys versus their noncoded analogs. J Biol Chem (2007) 1.28
Analysis and separation of residues important for the chemoattractant and antimicrobial activities of beta-defensin 3. J Biol Chem (2008) 1.28
Proinflammatory chemokines, such as C-C chemokine ligand 3, desensitize mu-opioid receptors on dorsal root ganglia neurons. J Immunol (2004) 1.27
TNFR2 is critical for the stabilization of the CD4+Foxp3+ regulatory T. cell phenotype in the inflammatory environment. J Immunol (2012) 1.26
Functional interaction of human neutrophil peptide-1 with the cell wall precursor lipid II. FEBS Lett (2010) 1.26
Structural basis of interaction between urokinase-type plasminogen activator and its receptor. J Mol Biol (2006) 1.25
Through the looking glass, mechanistic insights from enantiomeric human defensins. J Biol Chem (2009) 1.25
Reconstruction of the conserved beta-bulge in mammalian defensins using D-amino acids. J Biol Chem (2005) 1.25
Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin. J Biol Chem (2006) 1.25
Painful pathways induced by TLR stimulation of dorsal root ganglion neurons. J Immunol (2011) 1.24
A novel role for defensins in intestinal homeostasis: regulation of IL-1beta secretion. J Immunol (2007) 1.23
Expression of costimulatory TNFR2 induces resistance of CD4+FoxP3- conventional T cells to suppression by CD4+FoxP3+ regulatory T cells. J Immunol (2010) 1.23
Dying and necrotic neutrophils are anti-inflammatory secondary to the release of alpha-defensins. J Immunol (2009) 1.21
Identification of neutrophil granule protein cathepsin G as a novel chemotactic agonist for the G protein-coupled formyl peptide receptor. J Immunol (2004) 1.20
Multivalent binding of carbohydrates by the human alpha-defensin, HD5. J Immunol (2009) 1.20
TREM-like transcript-1 protects against inflammation-associated hemorrhage by facilitating platelet aggregation in mice and humans. J Clin Invest (2009) 1.20
Adenosine A2a receptors induce heterologous desensitization of chemokine receptors. Blood (2006) 1.19
Monocyte chemoattractant protein-1/CCL2 produced by stromal cells promotes lung metastasis of 4T1 murine breast cancer cells. PLoS One (2013) 1.18
Productive folding of human neutrophil alpha-defensins in vitro without the pro-peptide. J Am Chem Soc (2003) 1.18
Multifaceted mechanisms of HIV-1 entry inhibition by human α-defensin. J Biol Chem (2012) 1.18
Lactoferrin acts as an alarmin to promote the recruitment and activation of APCs and antigen-specific immune responses. J Immunol (2008) 1.18
Seroprevalence of antipolio antibodies among children <15 years of age in border provinces in China. Clin Vaccine Immunol (2013) 1.18
Why is the Arg5-Glu13 salt bridge conserved in mammalian alpha-defensins? J Biol Chem (2005) 1.17
The conserved salt bridge in human alpha-defensin 5 is required for its precursor processing and proteolytic stability. J Biol Chem (2008) 1.16
Systematic mutational analysis of peptide inhibition of the p53-MDM2/MDMX interactions. J Mol Biol (2010) 1.16
Pertussis toxin as an adjuvant suppresses the number and function of CD4+CD25+ T regulatory cells. Eur J Immunol (2006) 1.16
Neisseria gonorrhoeae-induced human defensins 5 and 6 increase HIV infectivity: role in enhanced transmission. J Immunol (2008) 1.15
TNF-alpha: an activator of CD4+FoxP3+TNFR2+ regulatory T cells. Curr Dir Autoimmun (2010) 1.14
Inhibition of pathologic retinal neovascularization by alpha-defensins. Blood (2005) 1.13